Regenerating Tissues for a Variety of Markets

Our platform technology simplifies regeneration and allows the cells to function naturally. With our launch product, SkinTE, we aim to be the first company to successfully supply an autologous construct to regenerate a patient’s skin due to a variety of injuries and conditions.

With success in the burn market, we plan to enter the acute and chronic wound markets, cosmetic/scar revision markets and an untapped hair regeneration market.

SkinTE
OsteoTE
AngioTE
MyoTE
CartTE
AdiposeTE
NeuralTE